These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 2869139)

  • 21. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
    Lerner RW; Lopaschuk GD; Catena RC; Olley PM
    Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competition for adenyl cyclase coupled (3H)-prostacyclin binding sites with prostaglandin E2 in rat peritoneal macrophages.
    Opmeer FA; Adolfs MJ; Bonta IL
    Prostaglandins; 1983 Sep; 26(3):467-76. PubMed ID: 6318272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets.
    Dutta-Roy AK; Sinha AK
    J Biol Chem; 1987 Sep; 262(26):12685-91. PubMed ID: 2887571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW; Stuart RK
    J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
    Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
    Sharif NA; Davis TL
    J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in binding sites for prostaglandin E2 on mononuclear leucocytes from human newborns and from their mothers.
    Johnsen SA; Olding LB
    Scand J Immunol; 1983 Apr; 17(4):389-94. PubMed ID: 6132443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific binding of prostaglandins E2 and F2alpha by membrane preparations from rat skin.
    Lord JT; Ziboh VA; Warren SK
    Endocrinology; 1978 Apr; 102(4):1300-9. PubMed ID: 744027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acetaldehyde on binding of prostaglandins by receptors of liver plasma membranes.
    Buko VU; Zavodnik IB
    Alcohol Alcohol; 1990; 25(5):483-7. PubMed ID: 1965121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
    Li SR; Yang Q; Wandl E; Pirker W; Virgolini I
    Br J Cancer; 1993 Oct; 68(4):695-701. PubMed ID: 7691143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E1 binding protein on the surface of primary cultured hepatocytes.
    Okumura T; Sago T; Saito K
    Biochem Int; 1987 Mar; 14(3):443-9. PubMed ID: 2884997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography.
    Eriksson LO; Larsson B; Hedlund H; Andersson KE
    Acta Physiol Scand; 1990 Jul; 139(3):393-404. PubMed ID: 2173350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of specific prostaglandin E receptor in isolated rat Leydig cells.
    Seböková E; Kolena J
    Endocrinol Exp; 1978 Sep; 12(3):147-56. PubMed ID: 213258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostaglandin receptors and prostaglandin metabolism in the terminal circulation of the brain].
    Wasinger T
    Wien Klin Wochenschr; 1989 Dec; 101(23):821-4. PubMed ID: 2514495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
    Anderson LE; Schultz MK; Wiltbank MC
    J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.